overseas tirzepatide FDA approval for Zepbound (tirzepatide) injection, the first and only obesity treatment of its kind that activates both GIP and GLP-1 hormone receptors - Eli Lilly Eli Lilly launches weight-loss drug

In plain terms, this means: After 5 days, about 50% of the drug remains After 10 days, about 25% remains After 15 days, about 12% remains After 2530 days, only trace amounts are left This long half-life is what allows tirzepatide to be taken as a once-weekly injection and explains why it takes time to fully leave your body

Enhanced Energy: With weight loss and better sugar control, many patients report feeling more energized

Many hormones in the body are peptide based signals, which is why peptide medicines are common in metabolic health

In clinical trials, tirzepatide has demonstrated a positive impact on lipid profiles, including reductions in total cholesterol and low-density lipoprotein cholesterol (LDL-C), often referred to as bad cholesterol